Long-acting biodegradable implants for osteoporosis management: transforming the landscape of bisphosphonates delivery

Affiliations

¹ Department of Pharmaceutical Science & Technology, Institute of Chemical Technology, Mumbai, Maharashtra, 400019, India.
² Department of Applied Physics, School of Science, Aalto University, Espoo, 00076, Finland.
³ Faculty of Biological & Environmental Sciences, University of Helsinki, Biocentre 3, Helsinki, 00014, Finland.
⁴ NanoSYD, Mads Clausen Institute, University of Southern Denmark, Alsion 2, Sønderborg, 6400, Denmark.
⁵ School of Pharmaceutical and Population Health Informatics, DIT University, Dehradun, Uttarakhand, 248009, India.

Editorial

Srushti Tambe et al. Future Med Chem. 2023 May.

. 2023 May;15(9):731-734.

doi: 10.4155/fmc-2023-0097. Epub 2023 May 11.

¹ Department of Pharmaceutical Science & Technology, Institute of Chemical Technology, Mumbai, Maharashtra, 400019, India.
² Department of Applied Physics, School of Science, Aalto University, Espoo, 00076, Finland.
³ Faculty of Biological & Environmental Sciences, University of Helsinki, Biocentre 3, Helsinki, 00014, Finland.
⁴ NanoSYD, Mads Clausen Institute, University of Southern Denmark, Alsion 2, Sønderborg, 6400, Denmark.
⁵ School of Pharmaceutical and Population Health Informatics, DIT University, Dehradun, Uttarakhand, 248009, India.

No abstract available

Keywords: bioavailability; biodegradable polymeric implants; bisphosphonates; controlled release; molecular targets; osteoporosis management.

Publication types